Parhaat The Lancet Infectious Diseases Podcastit (2024)

1
In Conversation With… Prasad Kulkarni on a dengue monoclonal antibody 18:53

10M ago18:53

18:53

Prasad Kulkarni discusses a new Phase I trial in The Lancet Infectious Diseases on a dengue monoclonal antibody also known as VIS513 in healthy adults. In addition, he highlights the wider implications of this for dengue control and drug development.Kirjoittanut The Lancet

1
Prasad Kulkarni on dengue monoclonal antibodies 18:53

10M ago18:53

18:53

Prasad Kulkarni discusses a new Phase I trial in The Lancet Infectious Diseases on a dengue monoclonal antibody also known as VIS513 in healthy adults. In addition, he highlights the wider implications of this for dengue control and drug development. Read the full article: https://www.thelancet.com/journals/laninf/article/ S1473-3099(24)00030-6/ful…

1
In conversation with... Oriol Mitjà 15:25

12M ago15:25

15:25

Oriol Mitjà discusses a new trial in The Lancet Infectious Diseases on the use of oral linezolid compared with benzathine penicillin G for the treatment of early syphilis in adults. He also highlights what the trial means for treatment of syphilis.Kirjoittanut The Lancet

1
Oriol Mitjà on treatment of early syphilis in adults 15:25

12M ago15:25

15:25

Oriol Mitjà discusses a new trial in The Lancet Infectious Diseases on the use of oral linezolid compared with benzathine penicillin G for the treatment of early syphilis in adults. He also highlights what the trial means for treatment of syphilis. Read the full article: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00683-7/ful…

1
In conversation with... Sofia Viegas and Stefan Niemann 24:35

1y ago24:35

24:35

Sofia Viegas and Stefan Niemann discuss a new article in The Lancet Infectious Diseases about emerging bedaquiline resistance in Mozambique and its implications for drug resistant tuberculosis and the fight to end tuberculosis.Kirjoittanut The Lancet

1
Sofia Viegas and Stefan Niemann on emerging bedaquiline resistance in Mozambique 24:35

1y ago24:35

24:35

Sofia Viegas and Stefan Niemann discuss a new article in The Lancet Infectious Diseases about emerging bedaquiline resistance in Mozambique and its implications for drug resistant tuberculosis and the fight to end tuberculosis. Read the full article: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00498-X/fulltext?dgcid=buzzsprou…

1
In conversation with... Luciano Moreira and Henrik Salje 17:01

2y ago17:01

17:01

Luciano Moreira and Henrik Salje discuss a new article in The Lancet Infectious Diseases describing the use of the Wolbachia bacteria to control the spread of mosquito-borne dengue and chikungunya in Rio de Janeiro, Brazil.Kirjoittanut The Lancet

1
Luciano Moreira and Henrik Salje on Wolbachia control of mosquito-borne infections 17:01

2y ago17:01

17:01

Luciano Moreira and Henrik Salje discuss a new article in The Lancet Infectious Diseases describing the use of the Wolbachia bacteria to control the spread of mosquito-borne dengue and chikungunya in Rio de Janeiro, Brazil. Read the full article: Estimating the effect of the wMel release programme on the incidence of dengue and chikungunya in Rio d…

1
Richard Maude on malaria chemoprophylaxis in Cambodia 12:44

2y ago12:44

12:44

Richard Maude discusses a new article in The Lancet Infectious Diseases that assesses the efficacy of malaria chemoprophylaxis among forest goers in Cambodia. Read the full article: Antimalarial chemoprophylaxis for forest goers in southeast Asia Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://insta…

1
In conversation with... Richard Maude 12:44

2y ago12:44

12:44

Richard Maude discusses a new article in The Lancet Infectious Diseases that assesses the efficacy of malaria chemoprophylaxis among forest goers in Cambodia.Kirjoittanut The Lancet

1
Ben Cowling on COVID-19 vaccines in Hong Kong 20:58

2+ y ago20:58

20:58

Ben Cowling discusses a new article in The Lancet Infectious Diseases describing the protection that vaccines are providing against COVID-19 in Hong Kong. Read the full article: Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong Continue this conversation on social! Follow us today at... https…

1
In conversation with... Ben Cowling 20:58

2+ y ago20:58

20:58

Ben Cowling discusses a new article in The Lancet Infectious Diseases describing the protection that vaccines are providing against COVID-19 in Hong Kong.Kirjoittanut The Lancet

1
Hugh Adler on monkeypox in the UK 18:17

2+ y ago18:17

18:17

Hugh Adler discusses a new article in The Lancet Infectious Diseases describing the management and the clinical features for seven patients with monkeypox hospitalised in the UK between 2018 and 2021. Read the full article: Clinical features and management of human monkeypox: a retrospective observational study in the UK Continue this conversation …

1
In conversation with... Hugh Adler 18:17

2+ y ago18:17

18:17

Hugh Adler discusses a new article in The Lancet Infectious Diseases describing the management and the clinical features for seven patients with monkeypox hospitalised in the UK between 2018 and 2021.Kirjoittanut The Lancet

1
In conversation with... Beate Kampmann, Karen Keddy, and Peter Ghazal 22:16

3y ago22:16

22:16

Prof Beate Kampmann, Dr Karen Keddy, and Prof Peter Ghazal discuss a new cross-journal Series in The Lancet Infectious Diseases and EBioMedicine addressing the potential for and challenge of applying big data to childhood infectious diseases in LMICsKirjoittanut The Lancet

1
Beate Kampmann, Karen Keddy, and Peter Ghazal on applying big data to childhood infectious diseases in LMICs 22:16

3y ago22:16

22:16

Prof Beate Kampmann, Dr Karen Keddy, and Prof Peter Ghazal discuss a new cross-journal Series in The Lancet Infectious Diseases and EBioMedicine addressing the potential for and challenge of applying big data to childhood infectious diseases in LMICs. Read the full Series: https://www.thelancet.com/series/big-data-childhood-infections-LMICs Continu…

1
Laura Cooper and Sam Okiror on polio eradication in Africa 21:34

3y ago21:34

21:34

A new article highlights how changing immunity profiles motivate the need for better responses to outbreaks of polio in Africa. Read the full article: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00453-9/fulltext Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/the…

1
In conversation with... Laura Cooper and Sam Okiror 21:34

3y ago21:34

21:34

A new Article in The Lancet Infectious Diseases highlights how changing immunity profiles motivate the need for better responses to outbreaks of polio in Africa.Kirjoittanut The Lancet

1
In conversation with... Paul Chapman 20:57

3+ y ago20:57

20:57

Paul Chapman and colleagues presents the results of an innovative trial assessing the safety of vaccinating healthy volunteers with attenuated Necator americanus hookworm larvae.Kirjoittanut The Lancet

1
Paul Chapman on a hookworm vaccine 20:57

3+ y ago20:57

20:57

Paul Chapman and colleagues presents the results of an innovative trial assessing the safety of vaccinating healthy volunteers with attenuated Necator americanus hookworm larvae. Read the full article: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00153-5/fulltext Continue this conversation on social! Follow us today at... http…

1
In conversation with... Josep Llibre 8:10

3+ y ago8:10

8:10

Josep Llibre discusses a trial on the impact of same-day testing for SARS-CoV-2 infection before a concert on new COVID-19 cases in Ba rcelona, Spain.Kirjoittanut The Lancet

1
Josep Llibre on preventing SARS-CoV-2 transmission at concerts 8:10

3+ y ago8:10

8:10

Josep Llibre discusses a trial on the impact of same-day testing for SARS-CoV-2 infection before a concert on new COVID-19 cases in Barcelona, Spain. Read the full article: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00268-1/fulltext Continue this conversation on social! Follow us today at... https://twitter.com/thelancet htt…

1
In Conversation With... Yap Boum 11:21

3+ y ago11:21

11:21

Yap Boum (MSF) discusses his study done in Cameroon, which developed a promising testing strategy for COVID-19 to optimise the available resource.Kirjoittanut The Lancet

1
Yap Boum on COVID-19 testing in low resource settings 11:21

3+ y ago11:21

11:21

Yap Boum (MSF) discusses his study done in Cameroon, which developed a promising testing strategy for COVID-19 to optimise the available resources. Read the full article: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00132-8/fulltext Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https…

1
Antimalarial resistance in southeast Asia 13:06

5+ y ago13:06

13:06

Two studies in The Lancet Infectious Diseases describe how the spread of resistance to both dihydroartemisinin and piperaquine is compromising malaria therapy in South-East Asia Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal …

1
Antimalarial resistance in southeast Asia 13:12

5+ y ago13:12

13:12

Two studies in The Lancet Infectious Diseases describe how the spread of resistance to both dihydroartemisinin and piperaquine is compromising malaria therapy in South-East AsiaKirjoittanut The Lancet

1
Trial in phage therapy for burn infections 29:29

6y ago29:29

29:29

A trial investigates the use of a cocktail of phages for the therapy of infections in patients with burns. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv…

1
Trial in phage therapy for burn infections 29:57

6y ago29:57

29:57

A trial investigates the use of a cocktail of phages for the therapy of infections in patients with burns.Kirjoittanut The Lancet

1
Pandemic influenza: 100 years 18:34

6+ y ago18:34

18:34

Editor of The Lancet Infectious Diseases, John McConnell, discusses the 1918 influenza pandemic and the lessons that can be learnt from it with John Oxford and Jeffery Taubenberger. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljour…

1
Pandemic influenza: 100 years 19:20

6+ y ago19:20

19:20

Editor of The Lancet Infectious Diseases, John McConnell, discusses the 1918 influenza pandemic and the lessons that can be learnt from it with John Oxford and Jeffery Taubenberger.Kirjoittanut The Lancet

1
Bedaquiline and delamanid combination for drug-resistant TB: The Lancet Infectious Diseases: February 13, 2018 14:11

7y ago14:11

14:11

Amir Shroufi discusses the early results assessing the safety and efficacy of the combination of bedaquiline and delamanid against drug-resistant tuberculosis. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.c…

1
Bedaquiline and delamanid combination for drug-resistant TB: The Lancet Infectious Diseases: February 13, 2018 15:16

7y ago15:16

15:16

Amir Shroufi discusses the early results assessing the safety and efficacy of the combination of bedaquiline and delamanid against drug-resistant tuberculosis.Kirjoittanut The Lancet

1
MERS and transchromosomic cows: The Lancet Infectious Diseases: January 10, 2018 12:48

7y ago12:48

12:48

John Beigel, an author, and Eddie Sullivan discuss a phase 1 study assessing the safety and tolerability of human antibodies manufactured in transchromosomic cows for treatment of MERS.Kirjoittanut The Lancet

1
MERS and transchromosomic cows: The Lancet Infectious Diseases: January 10, 2018 12:00

7y ago12:00

12:00

John Beigel, an author, and Eddie Sullivan discuss a phase 1 study assessing the safety and tolerability of human antibodies manufactured in transchromosomic cows for treatment of MERS. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedical…

1
PrEP in the UK: The Lancet Infectious Diseases: October 17, 2017 6:33

7y ago6:33

6:33

Valentina Cambiano discusses the cost-effectiveness of pre-exposure prophylaxis medication in the UK. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv…

1
PrEP in the UK: The Lancet Infectious Diseases: October 17, 2017 7:07

7y ago7:07

7:07

Valentina Cambiano discusses the cost-effectiveness of pre-exposure prophylaxis medication in the UK.Kirjoittanut The Lancet

1
Polio in Afghanistan: The Lancet Infectious Diseases: August 14, 2017 16:23

7+ y ago16:23

16:23

Christina Wayman talks to Gillian SteelFisher about polio vaccination in Afghanistan.Kirjoittanut The Lancet

1
Polio in Afghanistan: The Lancet Infectious Diseases: August 14, 2017 16:23

7+ y ago16:23

16:23

Christina Wayman talks to Gillian SteelFisher about polio vaccination in Afghanistan. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv…

1
Sexually transmitted infections: The Lancet Infectious Diseases: July 9, 2017 7:15

7+ y ago7:15

7:15

Kit Fairley discusses The Lancet Infectious Diseases' new Commission on sexually transmitted infections.Kirjoittanut The Lancet

1
Sexually transmitted infections: The Lancet Infectious Diseases: July 9, 2017 6:33

7+ y ago6:33

6:33

Kit Fairley discusses The Lancet Infectious Diseases' new Commission on sexually transmitted infections. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv…

1
Infectious diseases in China post-SARS: The Lancet Infectious Diseases: April 12, 2017 23:18

7+ y ago23:18

23:18

In our latest Chinese-language podcast, Linjuan Li discusses the epidemiology and evolution of infectious diseases in China in the decade since SARS with Lancet editor Helena Wang.Kirjoittanut The Lancet

1
Infectious diseases in China post-SARS: The Lancet Infectious Diseases: April 12, 2017 22:56

7+ y ago22:56

22:56

In our latest Chinese-language podcast, Linjuan Li discusses the epidemiology and evolution of infectious diseases in China in the decade since SARS with Lancet editor Helena Wang. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljourn…

1
MCR-1 in bacteraemia in China: The Lancet Infectious Diseases: January 27, 2017 20:45

8y ago20:45

20:45

In this special Chinese language podcast, Helena Wang is joined by two authors of papers on MCR-1 to discuss their research. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtu…

1
MCR-1 in bacteraemia in China: The Lancet Infectious Diseases: January 27, 2017 20:54

8y ago20:54

20:54

In this special Chinese language podcast, Helena Wang is joined by two authors of papers on MCR-1 to discuss their research.Kirjoittanut The Lancet

1
Inequities in Australian infectious diseases: The Lancet Infectious Diseases: 24 October 7:38

8y ago7:38

7:38

Katherine Gibney discusses her paper on geographic variations and sociodemographic inequities in infectious disease notifications in Australia. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-l…

1
Inequities in Australian infectious diseases: The Lancet Infectious Diseases: 24 October 7:47

8y ago7:47

7:47

Katherine Gibney discusses her paper on geographic variations and sociodemographic inequities in infectious disease notifications in Australia.Kirjoittanut The Lancet

1
TB Screening: The Lancet Infectious Diseases: March 21, 2016 9:49

9y ago9:49

9:49

Rob Aldridge discusses the prevalence of and risk factors for tuberculosis in UK migrant. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv…

1
TB Screening: The Lancet Infectious Diseases: March 21, 2016 10:51

9y ago10:51

10:51

Rob Aldridge discusses the prevalence of and risk factors for tuberculosis in UK migrant.Kirjoittanut The Lancet

1
Zika virus in amniotic fluid: The Lancet Infectious Diseases: February 17, 2016 9:49

9y ago9:49

9:49

Ana de Filippis discusses research on how Zika virus has been detected in the amniotic fluid of two pregnant women in Brazil. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://yout…

1
Zika virus in amniotic fluid: The Lancet Infectious Diseases: February 17, 2016 10:21

9y ago10:21

10:21

Ana de Filippis discusses research on how Zika virus has been detected in the amniotic fluid of two pregnant women in Brazil.Kirjoittanut The Lancet

Kuuntelemisen arvoisia podcasteja

The Lancet Infectious Diseases podcastit

Kuuntelemisen arvoisia podcasteja

Pikakäyttöopas